|
|
||||||||
The Journal of Immunology, Vol 158, Issue 7 3244-3251, Copyright © 1997 by American Association of Immunologists
ARTICLES |
Z Kurepa and J Forman
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235, USA.
We have analyzed the interaction of a nonameric peptide (Qdm) derived from the leader sequence of a MHC D region molecule with the class Ib molecule, Qa-1b. Using a direct binding assay with radiolabeled peptide on intact cells, we show specific binding of iodinated Qdm peptide to Qa-1b expressing cells. Specificity was confirmed by experiments in which the binding of iodinated peptide was blocked by unlabeled Qdm and not by control peptides. This allowed us to determine the on- and off- rate of peptide binding to Qa-1b, its binding affinity, and number of available peptide-binding sites per cell. Optimal binding occurs at 4 degrees C, and most of the binding to Qa-1b occurs within the first 10 min and peaks after 3 h. The dissociation of the peptide from cells has a t1/2 of approximately 10 h. The Kd is calculated between 0.2 and 1.1 x 10(-10) M, which is in the range or slightly higher than the Kd we measured for pMCMV to Ld (0.9 x 10(-10) M). The relatively high affinity of binding of the Qdm peptide and low dissociation rate could partially explain why a large portion of Qa-1b molecules are occupied with this single peptide species. We also changed each peptide residue to Ala or Gly to determine its effect on binding. Substitution of Leu at position 9 to Ala strongly reduced peptide binding, while changes at positions 2 (Met-->Ala) and 5 (Arg-->Ala) had a lesser effect. Binding to Qa-1b was completely abrogated with simultaneous Ala mutations at positions 2 and 9.
This article has been cited by other articles:
![]() |
X. Tang, I. Maricic, N. Purohit, B. Bakamjian, L. M. Reed-Loisel, T. Beeston, P. Jensen, and V. Kumar Regulation of Immunity by a Novel Population of Qa-1-Restricted CD8{alpha}{alpha}+TCR{alpha}beta+ T Cells J. Immunol., December 1, 2006; 177(11): 7645 - 7655. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Salerno-Goncalves, M. Fernandez-Vina, D. M. Lewinsohn, and M. B. Sztein Identification of a Human HLA-E-Restricted CD8+ T Cell Subset in Volunteers Immunized with Salmonella enterica Serovar Typhi Strain Ty21a Typhoid Vaccine J. Immunol., November 1, 2004; 173(9): 5852 - 5862. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kambayashi, J. R. Kraft-Leavy, J. G. Dauner, B. A. Sullivan, O. Laur, and P. E. Jensen The Nonclassical MHC Class I Molecule Qa-1 Forms Unstable Peptide Complexes J. Immunol., February 1, 2004; 172(3): 1661 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hui Jia, Z. Kurepa, A. Bai, and J. Forman Comparative Ability of Qdm/Qa-1b, Kb, and Db to Protect Class Ilow Cells from NK-Mediated Lysis In Vivo J. Immunol., December 1, 2000; 165(11): 6142 - 6147. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Soloski, M. E. Szperka, A. Davies, and S. L. Wooden Host Immune Response to Intracellular Bacteria: A Role for MHC-Linked Class-Ib Antigen-Presenting Molecules Experimental Biology and Medicine, September 1, 2000; 224(4): 231 - 239. [Abstract] [Full Text] |
||||
![]() |
J. R. Kraft, R. E. Vance, J. Pohl, A. M. Martin, D. H. Raulet, and P. E. Jensen Analysis of Qa-1b Peptide Binding Specificity and the Capacity of CD94/NKG2A to Discriminate between Qa-1-Peptide Complexes J. Exp. Med., August 28, 2000; 192(5): 613 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Sivakumar, A. Gunturi, M. Salcedo, J. D. Schatzle, W. C. Lai, Z. Kurepa, L. Pitcher, M. S. Seaman, F. A. Lemonnier, M. Bennett, et al. Cutting Edge: Expression of Functional CD94/NKG2A Inhibitory Receptors on Fetal NK1.1+Ly-49- Cells: A Possible Mechanism of Tolerance During NK Cell Development J. Immunol., June 15, 1999; 162(12): 6976 - 6980. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Vance, J. R. Kraft, J. D. Altman, P. E. Jensen, and D. H. Raulet Mouse CD94/NKG2A Is a Natural Killer Cell Receptor for the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule Qa-1b J. Exp. Med., November 16, 1998; 188(10): 1841 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mark Tompkins, J. R. Kraft, C. T. Dao, M. J. Soloski, and P. E. Jensen Transporters Associated with Antigen Processing (TAP)-independent Presentation of Soluble Insulin to alpha /beta T Cells by the Class Ib Gene Product, Qa-1b J. Exp. Med., September 7, 1998; 188(5): 961 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Kurepa, C. A. Hasemann, and J. Forman Qa-1b Binds Conserved Class I Leader Peptides Derived from Several Mammalian Species J. Exp. Med., September 7, 1998; 188(5): 973 - 978. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |